Merck Covid-19 Pill
- All
- News
- Videos
-
Chinese Cat Owners Are Feeding Covid-19 Pills To Their Pets. Here's Why
- Sunday January 5, 2025
- World News | Karoline Kan, Bloomberg
Merck & Co.'s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as antidotes to a life-threatening disease caused by a coronavirus that infects their feline companions.
-
www.ndtv.com
-
Merck's Covid Pill Not In India's Treatment Plan, Has Major Safety Concerns
- Thursday January 6, 2022
- India News | NDTV News Desk
India has not added Merck's pill to the list of treatments for Covid due to 'major safety concerns', a top health official said today.
-
www.ndtv.com
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
- Tuesday January 4, 2022
- India News | Reuters
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
www.ndtv.com
-
India Clears 2 New Vaccines And Merck's Covid Pill: 10 Points
- Tuesday December 28, 2021
- India News | Edited by Debanish Achom
The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the COVID-19 pandemic. The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.
-
www.ndtv.com
-
Now, 2 Covid Pills For At-Home Treatment As Omicron Spreads
- Friday December 24, 2021
- World News | Fiona Rutherford, Bloomberg
Merck & Co.'s Covid-19 pill was cleared by US regulators Thursday, giving high-risk patients a second at-home treatment just as the Omicron variant is causing cases to surge around the country.
-
www.ndtv.com
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
- Friday December 24, 2021
- World News | Josh Wingrove, Bloomberg
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
-
www.ndtv.com
-
Merck's Covid Pill Shows Lower Efficacy In Updated Data
- Friday November 26, 2021
- World News | Fiona Rutherford, Bloomberg
Merck & Co said updated results showed its Covid-19 pill reduced the risk of hospitalization or death among adults with mild to moderate disease by 30%, less than a previous estimate and well below a rival treatment from Pfizer Inc.
-
www.ndtv.com
-
EU Regulator Backs Merck Covid Pill, Says These Adults Can Take It
- Friday November 19, 2021
- World News | Agence France-Presse
The EU's medicines watchdog said on Friday that countries can use Merck's anti-Covid pill in emergencies caused by rising cases, ahead of the treatment's formal approval across the bloc.
-
www.ndtv.com
-
Why Top Drugmaker Is Surprisingly Downbeat About Covid Pill, Sputnik Shot
- Thursday November 18, 2021
- India News | Chris Kay, Bloomberg
For a drugmaker licensed to produce Merck & Co.'s promising Covid-19 pill and sell Russia's Sputnik V shot, Dr Reddy's Laboratories Ltd. is surprisingly mellow about the rewards it expects from these medical breakthroughs.
-
www.ndtv.com
-
Dr Reddy's Open To Making Pfizer Covid Pill
- Monday November 15, 2021
- India News | Reuters
Dr Reddy's Laboratories, one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said on Monday it was open to making a similar pill from Pfizer, thought to be even more effective.
-
www.ndtv.com
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
- Thursday November 11, 2021
- India News | Reported by Vishnu Som, Edited by Anindita Sanyal
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
www.ndtv.com
-
The Era Of Anti-Covid Pills: What You Need To Know
- Saturday November 6, 2021
- World News | Agence France-Presse
US pharma giants Merck and Pfizer have announced encouraging results for oral aniviral pills, in what could open up a new chapter in the fight against the COVID-19 pandemic.
-
www.ndtv.com
-
UK Becomes First Country To Approve Merck's Oral Covid Pill
- Thursday November 4, 2021
- World News | Reuters
Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.
-
www.ndtv.com
-
Hyderabad Firm Seeks Approval To Produce Generic Merck Covid Pill
- Thursday October 28, 2021
- India News | Reuters
The bulk drugs manufacturer Optimus Pharma is seeking domestic regulatory approval to produce a generic version of Merck & Co's oral COVID-19 treatment molnupiravir, the company's top executive told Reuters on Thursday.
-
www.ndtv.com
-
Gates Foundation To Spend $120 Million To Speed Access To Generics Of Merck Covid Pill
- Wednesday October 20, 2021
- World News | Reuters
The Bill & Melinda Gates Foundation said on Wednesday it would spend up to $120 million to kick-start development of generic versions of Merck & Co's oral COVID-19 treatment to help ensure lower-income countries have equal access to the drug.
-
www.ndtv.com
-
Chinese Cat Owners Are Feeding Covid-19 Pills To Their Pets. Here's Why
- Sunday January 5, 2025
- World News | Karoline Kan, Bloomberg
Merck & Co.'s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as antidotes to a life-threatening disease caused by a coronavirus that infects their feline companions.
-
www.ndtv.com
-
Merck's Covid Pill Not In India's Treatment Plan, Has Major Safety Concerns
- Thursday January 6, 2022
- India News | NDTV News Desk
India has not added Merck's pill to the list of treatments for Covid due to 'major safety concerns', a top health official said today.
-
www.ndtv.com
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
- Tuesday January 4, 2022
- India News | Reuters
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
www.ndtv.com
-
India Clears 2 New Vaccines And Merck's Covid Pill: 10 Points
- Tuesday December 28, 2021
- India News | Edited by Debanish Achom
The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the COVID-19 pandemic. The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.
-
www.ndtv.com
-
Now, 2 Covid Pills For At-Home Treatment As Omicron Spreads
- Friday December 24, 2021
- World News | Fiona Rutherford, Bloomberg
Merck & Co.'s Covid-19 pill was cleared by US regulators Thursday, giving high-risk patients a second at-home treatment just as the Omicron variant is causing cases to surge around the country.
-
www.ndtv.com
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
- Friday December 24, 2021
- World News | Josh Wingrove, Bloomberg
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
-
www.ndtv.com
-
Merck's Covid Pill Shows Lower Efficacy In Updated Data
- Friday November 26, 2021
- World News | Fiona Rutherford, Bloomberg
Merck & Co said updated results showed its Covid-19 pill reduced the risk of hospitalization or death among adults with mild to moderate disease by 30%, less than a previous estimate and well below a rival treatment from Pfizer Inc.
-
www.ndtv.com
-
EU Regulator Backs Merck Covid Pill, Says These Adults Can Take It
- Friday November 19, 2021
- World News | Agence France-Presse
The EU's medicines watchdog said on Friday that countries can use Merck's anti-Covid pill in emergencies caused by rising cases, ahead of the treatment's formal approval across the bloc.
-
www.ndtv.com
-
Why Top Drugmaker Is Surprisingly Downbeat About Covid Pill, Sputnik Shot
- Thursday November 18, 2021
- India News | Chris Kay, Bloomberg
For a drugmaker licensed to produce Merck & Co.'s promising Covid-19 pill and sell Russia's Sputnik V shot, Dr Reddy's Laboratories Ltd. is surprisingly mellow about the rewards it expects from these medical breakthroughs.
-
www.ndtv.com
-
Dr Reddy's Open To Making Pfizer Covid Pill
- Monday November 15, 2021
- India News | Reuters
Dr Reddy's Laboratories, one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said on Monday it was open to making a similar pill from Pfizer, thought to be even more effective.
-
www.ndtv.com
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
- Thursday November 11, 2021
- India News | Reported by Vishnu Som, Edited by Anindita Sanyal
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
www.ndtv.com
-
The Era Of Anti-Covid Pills: What You Need To Know
- Saturday November 6, 2021
- World News | Agence France-Presse
US pharma giants Merck and Pfizer have announced encouraging results for oral aniviral pills, in what could open up a new chapter in the fight against the COVID-19 pandemic.
-
www.ndtv.com
-
UK Becomes First Country To Approve Merck's Oral Covid Pill
- Thursday November 4, 2021
- World News | Reuters
Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.
-
www.ndtv.com
-
Hyderabad Firm Seeks Approval To Produce Generic Merck Covid Pill
- Thursday October 28, 2021
- India News | Reuters
The bulk drugs manufacturer Optimus Pharma is seeking domestic regulatory approval to produce a generic version of Merck & Co's oral COVID-19 treatment molnupiravir, the company's top executive told Reuters on Thursday.
-
www.ndtv.com
-
Gates Foundation To Spend $120 Million To Speed Access To Generics Of Merck Covid Pill
- Wednesday October 20, 2021
- World News | Reuters
The Bill & Melinda Gates Foundation said on Wednesday it would spend up to $120 million to kick-start development of generic versions of Merck & Co's oral COVID-19 treatment to help ensure lower-income countries have equal access to the drug.
-
www.ndtv.com